MAY 2ND, 2023 CONN HASTINGS EXCLUSIVE, NEUROLOGY, PSYCHIATRY GrayMatters Health, a medtech company based in Israel, has developed Prism for PTSD, a self-neuromodulation therapy. The company has identified what they describe as brain-mechanism-specific biomarkers for certain mental disorders. These involve combining fMRI and EEG data. The Prism for PTSD system targets a specific biomarker called amygdala-derived-EFP, which is involved...